Jakavi 5 Mg (Ruxolitinib)

Description :
Jakavi 5mg tablet contains the active constituent ruxolitinib. It is an anticancer agent that belongs to the class of kinase inhibitors. It is used to treat myelofibrosis ( a rare type of bone marrow cancer that causes decreased blood cell production). It is also used to treat polycythemia vera (a type of blood cancer where the body produces too many red blood cells) in people who are resistant or cannot be treated successfully with hydroxyurea. The medicine is also indicated to treat acute graft versus host disease (a complication of transplant procedure that replaced diseased bone marrow with healthy bone marrow) previously treated unsuccessfully with steroid medications in adults and children 12 years of age. It is also used for treating chronic graft versus host disease in adults and children 12 years of age and older who were treated unsuccessfully with 1 or 2 other systemic treatments.

Brand Name : Jakavi 5 mg
Composition : Ruxolitinib
Manufactured by : NOVARTIS INDIA LTD

Uses :
Polycythemia vera, Chronic idiopathic myelofibrosis

Medicinal Benefits :
Polycythemia vera is a type of blood cancer that causes excessive production of red blood cells. This may lead to blood clot formation and lead to other serious health issues. Jakavi 5mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

Directions for Use :
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jakavi 5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Side Effects :
Headache
Dizziness
Low blood platelets
Anemia (low number of red blood cells)